Remdesivir to receive emergency authorization as COVID-19 treatment; NIH launches $1.5b initiative to develop coronavirus test; Registration is open for MM&M Convene COVID-19 webcast.
Five things for pharma marketers to know: Thursday, April 23, 2020
Government to assist hospitals, doctors caring for uninsured patients; Study: Children with coronavirus recover within two weeks; Biogen delays Alzheimer’s drug submission.
Five things for pharma marketers to know: Thursday, April 16, 2020
WHO predicts 1 million coronavirus cases soon; FDA calls for removal of Zantac, other ranitidine drugs from the market; Is pharma taking full advantage of voice search?
Five things for pharma marketers to know: Thursday, March 26, 2020
Trump invokes emergency powers for medical supplies shortage; Younger people may experience serious health risks from COVID-19; #LetsFlattenTheCurve: An initiative to encourage social distancing.
Five things for pharma marketers to know: Thursday, March 12, 2020
White House tells health officials coronavirus meetings are classified; MM&M Madness launches social media campaign bracket; Americans’ concern about COVID-19 grows.
Five things for pharma marketers to know: Thursday, March 5, 2020